Post your job infront of 100,000+ qualified LP's and GP's.
Recently Filled Jobs
Firms you might be interested in
Posted on: Feb. 3, 2017, 11:47 a.m.
Vividion Therapeutics is launching with $50 million pledged from investment firms Arch Venture Partners and Versant Ventures. Former Celgene president of research and early development Tom Daniel—who, as Xconomy reported previously, left the company over the summer to begin advising biotechs and venture firms—is executive chairman. Full investment news articleRelevent to this post: ARCH Venture Partners Versant Ventures,